Quiz
Article
NeurologyLive® Brain Games: August 2, 2025
Author(s):
Key Takeaways
- NeurologyLive Brain Games offers weekly quizzes on diverse neurology topics, emphasizing dementia, epilepsy, and stroke.
- The quizzes are designed by experts and focus on clinical and historical aspects, with a special emphasis on Alzheimer’s disease.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on anti-amyloid treatments for Alzheimer disease.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions include the theme of the anti-amyloid treatments for Alzheimer disease.
Click here to check out the prior iterations of Brain Games.
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email: mmeglio@neurologylive.com.
Which biomarker is most commonly used to determine eligibility for anti-amyloid therapy in Alzheimer disease clinical trials?
Amyloid-related imaging abnormalities (ARIA) associated with anti-amyloid monoclonal antibodies most commonly involve which imaging finding?
Which factor is associated with increased risk of ARIA in patients receiving anti-amyloid therapy?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
